HIV, Tuberculosis, and Viral Hepatitis: Drugs, diagnostics, Vaccines, Immune-based therapies, and Preventive Technologies in Development. By Polly Clayden, Lei Chou, Simon Collins, Mark Harrington, Richard Jefferys, Eleonora Jimenez, Scott Morgan, Tracy Swan, Javid Syed and Claire Wingfield.
2009 TB Research Funding Trends, 2005 - 2008 - Second Edition March 2010 - This is an update to Treatment Action Group’s 2009 report on funding trends for tuberculosis (TB) research and development (R&D) from the baseline year 2005 through…
January 2010 - Despite being curable, Tuberculosis (TB) continues to be the leading cause of death among people with HIV in 2008, accounting for 25% of all HIV-related deaths. The World Health Organization (WHO) has developed a 12-point policy package…
2009 This publication by TAG and the International Community of Women Living with HIV–Eastern Africa (ICW) provides activists, policy makers, and donors with lessons learned from two years of capacity building for HIV treatment activists to integrate tuberculosis (TB) and…
Addressing Critical Challenges in TB/HIV Research & Program Implementation 1 December 2009, Cancun, Mexico Introduction About 70 activists, researchers, clinicians and public health experts participated in a TAG/Stop TB Partnership satellite meeting held prior to the 40th Union World Conference…
HIV, Tuberculosis, and Viral Hepatitis: Drugs, diagnostics, Vaccines, and Microbicides in Development July 2009 By Lei Chou, Mark Harrington, Bob Huff, Richard Jefferys, Javid Syed, and Claire Wingfield TAG’s annual Pipeline Reportsurveys the developments in medicines and diagnostics most likely…
Tuberculosis Research & Development: A Critical Analysis of Funding Trends, 2005–2007: An Update By Neha Agarwal May 2009 - For the third year, Treatment Action Group (TAG) analyzes and reports on the annual funding of tuberculosis (TB ) research and…
May 2009 by Lydia H. Guterman Edited by Mark Harrington Executive Summary The goal of this funding analysis is to provide a comprehensive picture of the current state of U.S. National Institutes of Health (NIH) research investment in HIV/AIDS and…